Overview

Medical Image Analysis Software Marketis poised to value over USD 4.8 billion by 2027 end at a CAGR of over 8% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Medical Image Analysis Software Markettrends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Medical Image Analysis Software Marketis anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Anti Epilepsy Drugs Market:
• AGFA Healthcare (Belgium)
• Aquilab (France)
• Carestream Health, Inc. (US)
• Esaote S.p.A (Italy)
• GE Healthcare (US)
• Image Analysis (UK)
• Infinitt Healthcare Co, Ltd. (South Korea)
• Merge Healthcare, Inc. (US)
• MIM Software Inc. (US)
• Irada Medical Limited (UK)
• Philips Healthcare (Netherlands)
• ScienceSoft USA Corporation (US)
• Siemens Healthineers (Germany)
• Toshiba Medical Systems Corporation (Japan)
• Xinapse Systems Ltd. (UK)

(Note: The list of the major players will be uRadiographic Imagingated with the latest market scenario and trends)

Medical Image Analysis Software Market Segmentation:
By Type
• Integrated Software
• Standalone Software

By Image Type
• 2D Imaging
• 3D Imaging
• 4D Imaging

By Application
• Orthopedics
• Dental Applications
• Neurology
• Cardiology
• Oncology
• Obstetrics and Gynecology
• Mammography
• Respiratory Applications
• Urology and Nephrology

By Modality
• Traumatic Brain Injury (TBI)
 o Computed Tomography (CT)
 o Magnetic Resonance Imaging (MRI)
 o Positron Emission Tomography (PET)
 o Single-photon Emission Computed Tomography (SPECT)
• Ultrasound Imaging
 o 2D Ultrasound Imaging
 o 3D/4D Ultrasound Imaging
 o Doppler Imaging
• Radiographic Imaging
• Combined Modalities
 o PET/CT
 o SPECT/CT
 o PET/MR

By End-user
• Hospitals
• Diagnostic Centers
• Research Centers
 
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Medical Image Analysis Software Market By Type,By Image Type,By Modality,By Application,By End-user and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Type  launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Medical Image Analysis Software MarketVariables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Anti Epilepsy Drugs Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Medical Image Analysis Software MarketAnalysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Medical Image Analysis Software Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Integrated Software
  7.2. Standalone Software
  7.3. Without Antibody (ELISA Based Assay)
  7.4. Clinical

8. Global Medical Image Analysis Software Market,By Image Type Historical Analysis and Forecast 2020-2027 (USD Million)  
  8.1. 2D Imaging
  8.2. 3D Imaging
  8.3. 4D Imaging

9. Global Anti Epilepsy Drugs Market,By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
  9.1. Orthopedics
  9.2. Dental Applications
  9.3. Neurology
  9.4. Cardiology
  9.5. Oncology
  9.6. Obstetrics and Gynecology
  9.7. Mammography
  9.8. Respiratory Applications
  9.9. Urology and Nephrology
 
10.Global Anti Epilepsy Drugs Market,By End-user Historical Analysis and Forecast 2020-2027 (USD Million)  
  10.1. Hospitals
  10.2. Diagnostic Centers
  10.3. Research Centers
       
11.Global Anti Epilepsy Drugs Market,By Modality Historical Analysis and Forecast 2020-2027 (USD Million)  
  11.1. Traumatic Brain Injury (TBI)
        11.1.1. Computed Tomography (CT)
        11.1.2. Magnetic Resonance Imaging (MRI)
        11.1.3. Positron Emission Tomography (PET)
        11.1.4. Single-photon Emission Computed Tomography (SPECT)
  11.2. Ultrasound Imaging
        11.2.1. 2D Ultrasound Imaging
        11.2.2. 3D/4D Ultrasound Imaging
        11.2.3. Doppler Imaging
  11.3. Radiographic Imaging
  11.4. Combined Modalities
        11.4.1. PET/CT
        11.4.2. SPECT/CT
        11.4.3. PET/MR
 
12. North America Medical Image Analysis Software Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       12.2.1. U.S.A
       12.2.2. Can3D Imaging
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Medical Image Analysis Software MarketAnalysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Medical Image Analysis Software Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Medical Image Analysis Software MarketAnalysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Saudi Arabia
         16.2.2. UAE
         16.2.3. South Africa
         16.2.4. Egypt
   16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4. North America - Market Share Analysis and Key Regional Players
   17.5. Europe - Market Share Analysis and Key Regional Players
   17.6. Asia Pacific - Market Share Analysis and Key Regional Players
   17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Type s Offered and Financial Layouts)
   18.1. AGFA Healthcare (Belgium)
         18.1.1. Company Overview
         18.1.2. Type  Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Aquilab (France)
         18.2.1. Company Overview
         18.2.2. Type  Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Carestream Health, Inc. (US)
         18.3.1. Company Overview
         18.3.2. Type  Portfolio          
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Esaote S.p.A (Italy)
         18.4.1. Company Overview
         18.4.2. Type  Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. GE Healthcare (US)
         18.5.1. Company Overview
         18.5.2. Type  Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Image Analysis (UK)
         18.6.1. Company Overview
         18.6.2. Type  Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Infinitt Healthcare Co, Ltd. (South Korea)
         18.7.1. Company Overview
         18.7.2. Type  Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.7. Merge Healthcare, Inc. (US)
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. MIM Software Inc. (US)
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Mirada Medical Limited (UK)
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10.Philips Healthcare (Netherlands)
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.ScienceSoft USA Corporation (US)
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12.Siemens Healthineers (Germany)
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.Toshiba Medical Systems Corporation (Japan)
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.Xinapse Systems Ltd. (UK)
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   
19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures